litlas
ログインアカウント作成

Ronenn Roubenoff

1987–2023 年に発表

137
論文数
31,977
被引用数
99
h 指数
136
i10 指数

被引用数

Ronenn Roubenoff の年別被引用数1978 年: 被引用 1 件1979 年: 被引用 1 件1982 年: 被引用 1 件1986 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 1 件1991 年: 被引用 6 件1992 年: 被引用 3 件1993 年: 被引用 7 件1994 年: 被引用 12 件1995 年: 被引用 20 件1996 年: 被引用 51 件1997 年: 被引用 50 件1998 年: 被引用 46 件1999 年: 被引用 84 件2000 年: 被引用 93 件2001 年: 被引用 136 件2002 年: 被引用 175 件2003 年: 被引用 249 件2004 年: 被引用 305 件2005 年: 被引用 370 件2006 年: 被引用 316 件2007 年: 被引用 282 件2008 年: 被引用 415 件2009 年: 被引用 403 件2010 年: 被引用 440 件2011 年: 被引用 359 件2012 年: 被引用 343 件2013 年: 被引用 379 件2014 年: 被引用 355 件2015 年: 被引用 344 件2016 年: 被引用 305 件2017 年: 被引用 259 件2018 年: 被引用 264 件2019 年: 被引用 734 件2020 年: 被引用 792 件2021 年: 被引用 718 件2022 年: 被引用 601 件2023 年: 被引用 495 件2024 年: 被引用 722 件2025 年: 被引用 407 件2026 年: 被引用 17 件1980〜1981 年は被引用が無いため表示していません1983〜1985 年は被引用が無いため表示していません1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,347 件、この内訳の 25.5%イギリス: 引用元論文 1,018 件、この内訳の 7.8%イタリア: 引用元論文 768 件、この内訳の 5.9%中国: 引用元論文 714 件、この内訳の 5.4%オーストラリア: 引用元論文 557 件、この内訳の 4.2%カナダ: 引用元論文 549 件、この内訳の 4.2%ドイツ: 引用元論文 507 件、この内訳の 3.9%オランダ: 引用元論文 461 件、この内訳の 3.5%スペイン: 引用元論文 412 件、この内訳の 3.1%フランス: 引用元論文 406 件、この内訳の 3.1%日本: 引用元論文 396 件、この内訳の 3%韓国: 引用元論文 354 件、この内訳の 2.7%
0%25.5%その他 27.7%

機関

分野

  • Medicine72.6%
  • Biochemistry, Genetics and Molecular Biology13.8%
  • Health Professions2.9%
  • Neuroscience2.4%
  • Nursing2.1%
  • Immunology and Microbiology1.5%
  • その他4.7%

トピック

  • Nutrition and Health in Aging12.9%
  • Body Composition Measurement Techniques5%
  • Frailty in Older Adults4.3%
  • Muscle Physiology and Disorders4.1%
  • Muscle metabolism and nutrition2.9%
  • Adipose Tissue and Metabolism1.8%
  • その他69%

共著者

全論文

検索で開く
  1. Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity

    著者: Steven B. Heymsfield, Laura A. Coleman, Ram R. Miller, Daniel Rooks, Didier Laurent, Olivier Pétricoul, Jens Præstgaard, Therese Swan, Thomas J. Wade, Robert G. Perry, Bret H. Goodpaster, Ronenn Roubenoff - JAMA Network Open 2021 被引用: 301

  2. Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project)

    著者: Roberto Bernabei, Francesco Landi, Riccardo Calvani, Matteo Cesari, Susanna Del Signore, Stefan D. Anker, Raphaël Bejuit, Philippe Bordes, Antonio Cherubini, Alfonso J. Cruz‐Jentoft, Mauro Di Bari, Tim Friede, Carmen Gorostiaga Ayestarán, Harmonie Goyeau, Pálmi V. Jónsson, Makoto Kashiwa, Fabrizia Lattanzio, Marcello Maggio, Luca Mariotti, Ram R. Miller, Leocadio Rodríguez‐Mañas, Regina Roller‐Wirnsberger, Ingrid Rýznarová, Joachim Scholpp, Annemie M.W.J. Schols, Cornel Sieber, Alan J. Sinclair, Anna Skalska, Timo Strandberg, Achille Tchalla, Eva Topinková, Matteo Tosato, Bruno Vellas, Stephan von Haehling, Marco Pahor, Ronenn Roubenoff, Emanuele Marzetti - BMJ 2022 被引用: 301

  3. The Healthcare Costs of Sarcopenia in the United States

    著者: Ian Janssen, Donald S. Shepard, Peter T. Katzmarzyk, Ronenn Roubenoff - Journal of the American Geriatrics Society 2003 被引用: 1,547

  4. Sarcopenia With Limited Mobility: An International Consensus

    著者: John E. Morley, Angela Marie Abbatecola, Josep M. Argilés, Vickie E. Baracos, Juergen Bauer, Shalender Bhasin, Tommy Cederholm, Andrew J.S. Coats, Steven R. Cummings, William J. Evans, Kenneth C.H. Fearon, Luigi Ferrucci, Roger A. Fielding, Jack M. Guralnik, Tamara B. Harris, Akio Inui, Kamyar Kalantar‐Zadeh, Bridget‐Anne Kirwan, Giovanni Mantovani, Maurizio Muscaritoli, Anne B. Newman, Filippo Rossi Fanelli, Giuseppe Rosano, Ronenn Roubenoff, Morris Schambelan, Gerald H. Sokol, Thomas W. Storer, Bruno Vellas, Stephan von Haehling, Shing-Shing Yeh, Stefan D. Anker - Journal of the American Medical Directors Association 2011 被引用: 1,127

  5. Does nutrition play a role in the prevention and management of sarcopenia?

    著者: Siân Robinson, Jean‐Yves Reginster, René Rizzoli, Sarah Shaw, J. A. Kanis, Ivan Bautmans, Heike A. Bischoff‐Ferrari, Olivier Bruyère, Matteo Cesari, Bess Dawson‐Hughes, R Fielding, Jean‐Marc Kaufman, Francesco Landi, Vincenzo Malafarina, Yves Rolland, Luc J. C. van Loon, Bruno Vellas, Marjolein Visser, Cyrus Cooper, Nasser M. Al‐Daghri, Sophie Allepaerts, Jürgen M. Bauer, Maria Luisa Brandi, Tommy Cederholm, Antonio Cherubini, Alfonso J. Cruz‐Jentoft, Alessandro Laviano, Stefania Maggi, Eugène McCloskey, Jean Pétermans, Ronenn Roubenoff, Ricardo Rueda - Clinical Nutrition 2017 被引用: 480

  6. Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement

    著者: Matthias Schieker, Philip G. Conaghan, Linda Mindeholm, Jens Præstgaard, Daniel H. Solomon, Celeste Scotti, Herman Gram, Tom Thurén, Ronenn Roubenoff, Paul M. Ridker - Annals of Internal Medicine 2020 被引用: 160

  7. Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults

    著者: Daniel Rooks, Therese Swan, Budhaditya Goswami, Lee Anne Filosa, Ola Bunte, Nicolas Panchaud, Laura A. Coleman, Ram R. Miller, Elisa Garcı́a Garayoa, Jens Præstgaard, Robert G. Perry, Chris Recknor, Charles Fogarty, Hidenori Arai, Liang‐Kung Chen, Jun Hashi­moto, Yoon‐Sok Chung, John Vissing, Didier Laurent, Olivier Pétricoul, Sarah Hemsley, Estelle Lach‐Trifilieff, Dimitris A. Papanicolaou, Ronenn Roubenoff - JAMA Network Open 2020 被引用: 160

  8. Aging of skeletal muscle: a 12-yr longitudinal study

    著者: Walter R. Frontera, Virginia Hughes, Roger A. Fielding, M. A. Fiatarone, William J. Evans, Ronenn Roubenoff - Journal of Applied Physiology 2000 被引用: 1,444

  9. Sarcopenia: no consensus, no diagnostic criteria, and no approved indication—How did we get here?

    著者: William J. Evans, Jack M. Guralnik, Peggy M. Cawthon, James Appleby, Francesco Landi, Lindsay Clarke, Bruno Vellas, Luigi Ferrucci, Ronenn Roubenoff - GeroScience 2023 被引用: 96

  10. Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial

    著者: Nicole Gerwin, Celeste Scotti, Christine Halleux, Mara Fornaro, Jimmy Elliott, Yunyu Zhang, Kristen Johnson, Jian Shi, Sandra Walter, Yufei Li, Carsten Jacobi, Nelly Laplanche, Magali Belaud, Jochen Paul, Gustavo Glowacki, Thomas Peters, Keith A. Wharton, Igor Voštiar, Florine Polus, Ina Krämer, Sabine Guth, Abdelkader Seroutou, Subhajit Choudhury, Didier Laurent, Joseph Gimbel, Jörg Goldhahn, Matthias Schieker, Sophie Brachat, Ronenn Roubenoff, Michaela Kneissel - Nature Medicine 2022 被引用: 60

  11. Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study

    著者: Daniel Rooks, Jens Præstgaard, Sam Hariry, Didier Laurent, Olivier Pétricoul, Robert G. Perry, Estelle Lach‐Trifilieff, Ronenn Roubenoff - Journal of the American Geriatrics Society 2017 被引用: 228

  12. Longitudinal Muscle Strength Changes in Older Adults: Influence of Muscle Mass, Physical Activity, and Health

    著者: Virginia Hughes, Walter R. Frontera, Michael Wood, W. J. Evans, Gerard E. Dallal, Ronenn Roubenoff, M. A. F. Singh - The Journals of Gerontology Series A 2001 被引用: 925

  13. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy

    著者: Andrew J. Westwood, Alexa Beiser, Charles DeCarli, Tamara B. Harris, Tai C. Chen, Xuemei He, Ronenn Roubenoff, Aleksandra Pikula, Rhoda Au, Lewis E. Braverman, Philip A. Wolf, Ramachandran S. Vasan, Sudha Seshadri - Neurology 2014 被引用: 218

  14. A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach

    著者: Lynn Rochester, Claudia Mazzà, Arne Mueller, Brian Caulfield, Marie Mc Carthy, Clemens Becker, Ram R. Miller, Paolo Piraino, Marco Viceconti, Wilhelmus Dartee, Judith García‐Aymerich, Aida Aydemir, Beatrix Vereijken, Valdo Arnera, Nadir Ammour, Michael P. Jackson, Tilo Hache, Ronenn Roubenoff - Digital Biomarkers 2020 被引用: 142

  15. Sarcopenia

    著者: John E. Morley, Richard Baumgartner, Ronenn Roubenoff, Jean Mayer, K. Sreekumaran Nair - Journal of Laboratory and Clinical Medicine 2001 被引用: 937

  16. Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction

    著者: Ramachandran S. Vasan, Lisa Sullivan, Ronenn Roubenoff, Charles A. Dinarello, Tamara B. Harris, Emelia J. Benjamin, Douglas B. Sawyer, Daniel Levy, Peter W.F. Wilson, Ralph B. D’Agostino - Circulation 2003 被引用: 743

  17. Sarcopenic Obesity: The Confluence of Two Epidemics

    著者: Ronenn Roubenoff - Obesity Research 2004 被引用: 457

  18. Inflammatory markers and the risk of Alzheimer disease

    著者: Zaldy S. Tan, Alexa Beiser, Ramachandran S. Vasan, Ronenn Roubenoff, Charles A. Dinarello, Tamara B. Harris, Emelia J. Benjamin, Rhoda Au, Douglas P. Kiel, P. A. Wolf, Sudha Seshadri - Neurology 2007 被引用: 432

  19. A Randomized Controlled Trial of Resistance Exercise Training to Improve Glycemic Control in Older Adults With Type 2 Diabetes

    著者: Carmen Castañeda, Jennifer E. Layne, Leda Munoz-Orians, Patricia Gordon, Joseph Walsmith, Mona Foldvari, Ronenn Roubenoff, Katherine L. Tucker, Miriam E. Nelson - Diabetes Care 2002 被引用: 846

  20. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity

    著者: Virginia Hughes, Walter R. Frontera, Ronenn Roubenoff, William J. Evans, Maria A. Fiatarone Singh - American Journal of Clinical Nutrition 2002 被引用: 803

  21. Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on Sarcopenia

    著者: Matteo Cesari, Roger A. Fielding, Marco Pahor, Bret H. Goodpaster, Marc K. Hellerstein, Gabor Abellán van Kan, Stefan D. Anker, Seward B. Rutkove, Jan W. Vrijbloed, Maria Isaac, Yves Rolland, Christine M’Rini, Mylène Aubertin‐Leheudre, Jesse M. Cedarbaum, Mauro Zamboni, Cornel Sieber, Didier Laurent, William J. Evans, Ronenn Roubenoff, John E. Morley, Bruno Vellas - Journal of Cachexia Sarcopenia and Muscle 2012 被引用: 293

  22. Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort

    著者: Daniel Rooks, Olivier Pétricoul, Jens Præstgaard, Michael G. Bartlett, Didier Laurent, Ronenn Roubenoff - Journal of Cachexia Sarcopenia and Muscle 2020 被引用: 49

  23. Reproducibility, relevance and reliability as barriers to efficient and credible biomedical technology translation

    著者: Ulrich Dirnagl, Georg N. Duda, David W. Grainger, Petra Reinke, Ronenn Roubenoff - Advanced Drug Delivery Reviews 2022 被引用: 62

  24. Sarcopenia and its implications for the elderly

    著者: Ronenn Roubenoff - European Journal of Clinical Nutrition 2000 被引用: 467